CODX vs GS
Co-Diagnostics, Inc. Common Stock (CODX) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
GS does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the CODX and GS stock pages for the full models.
Not investment advice.